February 24, 2026

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

Conexiant

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 23, 2026

Lifestyle Interventions vs Gestational Diabetes

Investigators report that lifestyle interventions during pregnancy reduce gestational diabetes risk, with effects varying by diagnostic criteria and maternal education level.

Conexiant

February 23, 2026

Hypertension: Biomarkers Clarify Heart Failure Risk

Cardiac biomarkers help stratify heart failure risk among patients with prediabetes and hypertension.

Conexiant

February 19, 2026

Income, BMI Linked to Colon Capsule Completion

Danish screening data identify clinical and socioeconomic factors that significantly influence whether colon capsule exams are completed.

Conexiant

February 19, 2026

BP Targets Across CKM Stages

Investigators assess stage-specific outcomes, safety, and net benefit of intensive blood pressure control in cardiovascular-kidney-metabolic syndrome.

Conexiant

February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 18, 2026

Medical Oddities: Essential Oil, Deadly Consequences

A cabinet mix-up, a chatty heart, a violet catheter bag, stressed kids, and tea that won’t save the brain—just another week.

Conexiant

February 18, 2026

Creatinine Index Linked to CKD Mortality

Prospective UK cohort study links higher creatinine muscle index to lower odds of probable sarcopenia and reduced pre–kidney replacement therapy mortality.

Conexiant